Use cautiously with sulfonylureas or insulin due to risk of hypoglycemia
The duration of Semaglutide GLP-1 treatment for weight loss depends on various factors, including the individuals weight loss goals, response to the medication, and overall health
A 41-year-old woman with brain fog, insomnia, vertigo, neuropathic symptoms, blood pressure lability, postural orthostatic tachycardia syndrome (POTS), dermatographism, macular erythematous rash, flushing, burning skin, severe gastroesophageal reflux, migratory joint pains, vaginal pruritus, intermittent hoarseness, and chemical sensitivity
Studies suggest 40% or more of patients experience some degree of volume loss in the buttocks during significant weight loss from these weight loss drugs
two patients on the same dose can react differently